Top

Current Cardiology Reports

Published in:

01-09-2018 | Congenital Heart Disease (RA Krasuski, Section Editor)

Resynchronization Therapy for Patients with Congenital Heart Disease: Are We Ready for Prime Time?

Authors: Scott Anjewierden, Peter F. Aziz

Published in: Current Cardiology Reports | Issue 9/2018

Abstract

Purpose of Review

This review aims to summarize and provide an update of evidence for cardiac resynchronization therapy (CRT) in pediatric and adult congenital heart disease (CHD).

Recent Findings

CRT is a valuable tool in the treatment of heart failure in the setting of CHD. Current evidence points toward the ability of this therapy to increase hemodynamic parameters and reduce heart failure-related symptoms. Within the CHD population, patients with systemic left ventricles appear to benefit the most from CRT. Utilization of CRT in CHD has been technically difficult due to the complexity and variety of anatomic substrates. However, lateral thoracotomies and other advances have made implantation more feasible.

Summary

The most up-to-date evidence continues to support the use of CRT in the heterogeneous population of CHD with careful and individualized patient selection. Further studies are needed to evaluate the utility of CRT for specific anatomic substrates within this population.

Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127:e6–245. https://doi.org/10.1161/CIR.0b013e31828124ad.CrossRefPubMed

Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, et al. 2013 ACCF/AHA guideline for the Management of Heart Failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128:e240–327. https://doi.org/10.1161/CIR.0b013e31829e8776.CrossRefPubMed

•• Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344:873–80. https://doi.org/10.1056/NEJM200103223441202. This is the first large study to demonstrate a clinical benefit to cardiac resynchronization therapy. CrossRefPubMed

• Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346:1845–53. https://doi.org/10.1056/NEJMoa013168. This trial demonstrated that CRT is an effective adjunctive in reducing the combined endpoint of HF hospitalizations and death. CrossRefPubMed

St John Sutton MG, Plappert T, Abraham WT, Smith AL, DeLurgio DB, Leon AR, et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation. 2003;107:1985–90. https://doi.org/10.1161/01.CIR.0000065226.24159.E9.CrossRefPubMed

•• Cleland JGF, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539–49. https://doi.org/10.1056/NEJMoa050496. This is the first trial to show definitively that CRT had a mortality benefit, even in the absence of cardioverter defibrillator (ICD) therapy. CrossRefPubMed

McAlister FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, Dryden DM, et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA. 2007;297:2502–14. https://doi.org/10.1001/jama.297.22.2502.CrossRefPubMed

Al-Majed NS, McAlister FA, Bakal JA, Ezekowitz JA. Meta-analysis: cardiac resynchronization therapy for patients with less symptomatic heart failure. Ann Intern Med. 2011;154:401–12. https://doi.org/10.7326/0003-4819-154-6-201103150-00313.CrossRefPubMed

Adabag S, Roukoz H, Anand IS, Moss AJ. Cardiac resynchronization therapy in patients with minimal heart failure: a systematic review and meta-analysis. J Am Coll Cardiol. 2011;58:935–41. https://doi.org/10.1016/j.jacc.2011.05.022.CrossRefPubMed

10.

Khairy P, Van Hare GF, Balaji S, Berul CI, Cecchin F, Cohen MI, et al. PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm. 2014;11:e102–65. https://doi.org/10.1016/j.hrthm.2014.05.009.CrossRefPubMed

11.

•• Kirk JA, Kass DA. Cellular and molecular aspects of dyssynchrony and resynchronization. Heart Fail Clin. 2017;13:29–41. https://doi.org/10.1016/j.hfc.2016.07.003. This paper provides an excellent review of the molecular mechanisms underlying the clinical benefit of CRT. CrossRefPubMed

12.

Prinzen FW, Hunter WC, Wyman BT, McVeigh ER. Mapping of regional myocardial strain and work during ventricular pacing: experimental study using magnetic resonance imaging tagging. J Am Coll Cardiol. 1999;33:1735–42. https://doi.org/10.1016/S0735-1097(99)00068-6.CrossRefPubMedPubMedCentral

13.

Nelson GS, Berger RD, Fetics BJ, Talbot M, Spinelli JC, Hare JM, et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation. 2000;102:3053–9. https://doi.org/10.1161/01.CIR.102.25.3053.CrossRefPubMed

14.

Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–50. https://doi.org/10.1056/NEJMoa032423.CrossRefPubMed

15.

Prinzen FW, Vernooy K, De Boeck BWL, DeBoeck BWL, Delhaas T. Mechano-energetics of the asynchronous and resynchronized heart. Heart Fail Rev. 2011;16:215–24. https://doi.org/10.1007/s10741-010-9205-3.CrossRefPubMed

16.

Verbeek XAAM, Vernooy K, Peschar M, Cornelussen RNM, Prinzen FW. Intra-ventricular resynchronization for optimal left ventricular function during pacing in experimental left bundle branch block. J Am Coll Cardiol. 2003;42:558–67.CrossRefPubMed

17.

St John Sutton M, Cerkvenik J, Borlaug BA, Daubert C, Gold MR, Ghio S, et al. Effects of cardiac resynchronization therapy on cardiac remodeling and contractile function: results from Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE). J Am Heart Assoc. 2015;4:e002054. doi:10.1161/JAHA.115.002054.CrossRef

18.

Pieragnoli P, Perego GB, Ricciardi G, Sacchi S, Padeletti M, Michelucci A, et al. Cardiac resynchronization therapy acutely improves ventricular-arterial coupling by reducing the arterial load: assessment by pressure-volume loops. Pacing Clin Electrophysiol PACE. 2015;38:431–7. https://doi.org/10.1111/pace.12585.CrossRefPubMed

19.

Reddy VY, Miller MA, Neuzil P, Søgaard P, Butter C, Seifert M, et al. Cardiac resynchronization therapy with wireless left ventricular endocardial pacing: The SELECT-LV study. J Am Coll Cardiol. 2017;69:2119–29. https://doi.org/10.1016/j.jacc.2017.02.059.CrossRefPubMed

20.

Auricchio A, Prinzen FW. Enhancing response in the cardiac resynchronization therapy patient: the 3B perspective—bench, bits, and bedside. JACC Clin Electrophysiol. 2017;3:1203–19. https://doi.org/10.1016/j.jacep.2017.08.005.CrossRefPubMed

21.

•• Dubin AM, Janousek J, Rhee E, Strieper MJ, Cecchin F, Law IH, et al. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol. 2005;46:2277–83. https://doi.org/10.1016/j.jacc.2005.05.096. This is a landmark large multicenter study of CRT in pediatric and adult congenital heart disease. CrossRefPubMed

22.

•• Janoušek J, Gebauer RA, Abdul-Khaliq H, Turner M, Kornyei L, Grollmuß O, et al. Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates. Heart. 2009;95:1165–71. https://doi.org/10.1136/hrt.2008.160465. This is the largest study of CRT in congenital heart disease to date. CrossRefPubMedPubMedCentral

23.

Janous̆ek J, Tomek V, Chaloupecký V, Reich O, Gebauer RA, Kautzner J, et al. Cardiac resynchronization therapy: a novel adjunct to the treatment and prevention of systemic right ventricular failure. J Am Coll Cardiol. 2004;44:1927–31. https://doi.org/10.1016/j.jacc.2004.08.044.CrossRefPubMed

24.

Strieper M, Karpawich P, Frias P, Gooden K, Ketchum D, Fyfe D, et al. Initial experience with cardiac resynchronization therapy for ventricular dysfunction in young patients with surgically operated congenital heart disease. Am J Cardiol. 2004;94:1352–4. https://doi.org/10.1016/j.amjcard.2004.07.134.CrossRefPubMed

25.

Moak JP, Hasbani K, Ramwell C, Freedenberg V, Berger JT, Dirusso G, et al. Dilated cardiomyopathy following right ventricular pacing for AV block in young patients: resolution after upgrading to biventricular pacing systems. J Cardiovasc Electrophysiol. 2006;17:1068–71. https://doi.org/10.1111/j.1540-8167.2006.00565.x.CrossRefPubMed

26.

Khairy P, Fournier A, Thibault B, Dubuc M, Thérien J, Vobecky SJ. Cardiac resynchronization therapy in congenital heart disease. Int J Cardiol. 2006;109:160–8. https://doi.org/10.1016/j.ijcard.2005.06.065.CrossRefPubMed

27.

Jauvert G, Rousseau-Paziaud J, Villain E, Iserin L, Hidden-Lucet F, Ladouceur M, et al. Effects of cardiac resynchronization therapy on echocardiographic indices, functional capacity, and clinical outcomes of patients with a systemic right ventricle. Europace. 2009;11:184–90. https://doi.org/10.1093/europace/eun319.CrossRefPubMed

28.

• Cecchin F, Frangini PA, Brown DW, Fynn-Thompson F, Alexander ME, Triedman JK, et al. Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years’ experience in a single institution. J Cardiovasc Electrophysiol. 2009;20:58–65. https://doi.org/10.1111/j.1540-8167.2008.01274.x. This is the largest single-center assessment of CRT in pediatric and adult CHD. CrossRefPubMed

29.

Perera J, Motonaga KS, Miyake CY, Avasarala K, Punn R, Tierney E, et al. Does pediatric CRT increase the risk of ventricular tachycardia [abstract]? Heart Rhythm. 2013:S210–1.

30.

Thambo J-B, Guillebon MD, Xhaet O, Santos PD, Roubertie F, Labrousse L, et al. Biventricular pacing in patients with Tetralogy of Fallot: non-invasive epicardial mapping and clinical impact. Int J Cardiol. 2013;163:170–4. https://doi.org/10.1016/j.ijcard.2011.06.005.CrossRefPubMed

31.

Sakaguchi H, Miyazaki A, Yamada O, Kagisaki K, Hoashi T, Ichikawa H, et al. Cardiac resynchronization therapy for various systemic ventricular morphologies in patients with congenital heart disease. Circ J. 2015;79:649–55. https://doi.org/10.1253/circj.CJ-14-0395.CrossRefPubMed

32.

Janousek J, Vojtovic P, Hucín B, Tláskal T, Gebauer RA, Gebauer R, et al. Resynchronization pacing is a useful adjunct to the management of acute heart failure after surgery for congenital heart defects. Am J Cardiol. 2001;88:145–52.CrossRefPubMed

33.

Gleva MJ, Wang Y, Curtis JP, Berul CI, Huddleston CB, Poole JE. Complications associated with implantable cardioverter defibrillators in adults with congenital heart disease or left ventricular noncompaction cardiomyopathy (from the NCDR® Implantable Cardioverter-Defibrillator Registry). Am J Cardiol. 2017;120:1891–8. https://doi.org/10.1016/j.amjcard.2017.07.103.CrossRefPubMed

34.

Zimmerman FJ, Starr JP, Koenig PR, Smith P, Hijazi ZM, Bacha EA. Acute hemodynamic benefit of multisite ventricular pacing after congenital heart surgery. Ann Thorac Surg. 2003;75:1775–80.CrossRefPubMed

35.

Dubin AM, Feinstein JA, Reddy VM, Hanley FL, Van Hare GF, Rosenthal DN. Electrical resynchronization: a novel therapy for the failing right ventricle. Circulation. 2003;107:2287–9. https://doi.org/10.1161/01.CIR.0000070930.33499.9F.CrossRefPubMed

36.

Bacha EA, Zimmerman FJ, Mor-Avi V, Weinert L, Starr JP, Sugeng L, et al. Ventricular resynchronization by multisite pacing improves myocardial performance in the postoperative single-ventricle patient. Ann Thorac Surg. 2004;78:1678–83. https://doi.org/10.1016/j.athoracsur.2004.04.065.CrossRefPubMed

37.

Pham PP, Balaji S, Shen I, Ungerleider R, Li X, Sahn DJ. Impact of conventional versus biventricular pacing on hemodynamics and tissue Doppler imaging indexes of resynchronization postoperatively in children with congenital heart disease. J Am Coll Cardiol. 2005;46:2284–9. https://doi.org/10.1016/j.jacc.2005.08.036.CrossRefPubMed

38.

Bordachar P, Iriart X, Chabaneix J, Sacher F, Lafitte S, Jais P, et al. Presence of ventricular dyssynchrony and haemodynamic impact of right ventricular pacing in adults with repaired Tetralogy of Fallot and right bundle branch block. Europace. 2008;10:967–71. https://doi.org/10.1093/europace/eun178.CrossRefPubMed

39.

Thambo J-B, Dos Santos P, De Guillebon M, Roubertie F, Labrousse L, Sacher F, et al. Biventricular stimulation improves right and left ventricular function after tetralogy of Fallot repair: acute animal and clinical studies. Heart Rhythm. 2010;7:344–50. https://doi.org/10.1016/j.hrthm.2009.11.019.CrossRefPubMed

40.

Plymen CM, Finlay M, Tsang V, O’leary J, Picaut N, Cullen S, et al. Haemodynamic consequences of targeted single- and dual-site right ventricular pacing in adults with congenital heart disease undergoing surgical pulmonary valve replacement. Europace. 2015;17:274–80. https://doi.org/10.1093/europace/euu281.CrossRefPubMed

41.

•• Friedberg MK, Schwartz SM, Zhang H, Chiu-Man C, Manlhiot C, Ilina MV, et al. Hemodynamic effects of sustained postoperative cardiac resynchronization therapy in infants after repair of congenital heart disease: results of a randomized clinical trial. Heart Rhythm. 2017;14:240–7. https://doi.org/10.1016/j.hrthm.2016.09.025. This is the first RCT of acute CRT following surgery in pediatric patients with CHD less than 4 months of age showed improved blood pressure and a trend toward higher cardiac index. CrossRefPubMed

42.

•• Janoušek J, Kovanda J, Ložek M, Tomek V, Vojtovič P, Gebauer R, et al. Pulmonary right ventricular resynchronization in congenital heart disease: acute improvement in right ventricular mechanics and contraction efficiency. Circ Cardiovasc Imaging. 2017;10:e006424. https://doi.org/10.1161/CIRCIMAGING.117.006424. This is the first study to demonstrate the hemodynamic benefit of acute pulmonary RV resynchronization in the postoperative setting. CrossRefPubMed

43.

Vojtovic P, Kucera F, Kubuš P, Gebauer R, Matejka T, Tláskal T, et al. Acute right ventricular resynchronization improves haemodynamics in children after surgical repair of tetralogy of Fallot. Europace. 2018;20:323–8. https://doi.org/10.1093/europace/euw414.CrossRefPubMed

44.

European Heart Rhythm Association, European Society of Cardiology, Heart Rhythm Society, Heart Failure Society of America, American Society of Echocardiography, American Heart Association, et al. 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Heart Rhythm. 2012;9:1524–76. https://doi.org/10.1016/j.hrthm.2012.07.025.CrossRef

45.

Hummel JD, Coppess MA, Osborn JS, Yee R, Fung JWH, Augostini R, et al. Real-world assessment of acute left ventricular lead implant success and complication rates: results from the attain success clinical trial. Pacing Clin Electrophysiol. 2016;39:1246–53. https://doi.org/10.1111/pace.12939.CrossRefPubMed

46.

Lickfett L, Bitzen A, Arepally A, Nasir K, Wolpert C, Jeong KM, et al. Incidence of venous obstruction following insertion of an implantable cardioverter defibrillator. A study of systematic contrast venography on patients presenting for their first elective ICD generator replacement. Europace. 2004;6:25–31.CrossRefPubMed

47.

Abu-El-Haija B, Bhave PD, Campbell DN, Mazur A, Hodgson-Zingman DM, Cotarlan V, et al. Venous stenosis after transvenous lead placement: a study of outcomes and risk factors in 212 consecutive patients. J Am Heart Assoc. 2015;4:e001878. https://doi.org/10.1161/JAHA.115.001878.CrossRefPubMedPubMedCentral

48.

Kaypakli O, Koç M, Gözübüyük G, Şahin DY. High left ventricular lead sensing delay predicts QRS narrowing and good response to cardiac resynchronization therapy. Pacing Clin Electrophysiol. 2016;39:1317–26. https://doi.org/10.1111/pace.12963.CrossRefPubMed

49.

Chatterjee NA, Gold MR, Waggoner AD, Picard MH, Stein KM, Yu Y, et al. Longer left ventricular electric delay reduces mitral regurgitation after cardiac resynchronization therapy: mechanistic insights from the SMART-AV study (SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy). Circ Arrhythm Electrophysiol. 2016;9:e004346. https://doi.org/10.1161/CIRCEP.116.004346.CrossRefPubMed

50.

Brenyo A, Kutyifa V, Moss AJ, Mathias A, Barsheshet A, Pouleur A-C, et al. Atrioventricular delay programming and the benefit of cardiac resynchronization therapy in MADIT-CRT. Heart Rhythm. 2013;10:1136–43. https://doi.org/10.1016/j.hrthm.2013.04.013.CrossRefPubMed

51.

Singh JP, Klein HU, Huang DT, Reek S, Kuniss M, Quesada A, et al. Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial. Circulation. 2011;123:1159–66. https://doi.org/10.1161/CIRCULATIONAHA.110.000646.CrossRefPubMed

52.

Rickard J, Cheng A, Spragg D, Cantillon D, Chung MK, Tang WHW, et al. QRS narrowing is associated with reverse remodeling in patients with chronic right ventricular pacing upgraded to cardiac resynchronization therapy. Heart Rhythm. 2013;10:55–60. https://doi.org/10.1016/j.hrthm.2012.09.018.CrossRefPubMed

53.

Cobb DB, Gold MR. The role of atrioventricular and interventricular optimization for cardiac resynchronization therapy. Heart Fail Clin. 2017;13:209–23. https://doi.org/10.1016/j.hfc.2016.07.017.CrossRefPubMed

54.

Beaufort-Krol GC, Mulder H, Nagelkerke D, Waterbolk TW, Bink-Boelkens MT. Comparison of longevity, pacing, and sensing characteristics of steroid-eluting epicardial versus conventional endocardial pacing leads in children. J Thorac Cardiovasc Surg. 1999;117:523–8.CrossRefPubMed

55.

Ramesh V, Gaynor JW, Shah MJ, Wieand TS, Spray TL, Vetter VL, et al. Comparison of left and right atrial epicardial pacing in patients with congenital heart disease. Ann Thorac Surg. 1999;68:2314–9.CrossRefPubMed

56.

Paech C, Kostelka M, Dähnert I, Flosdorff P, Riede FT, Gebauer RA. Performance of steroid eluting bipolar epicardial leads in pediatric and congenital heart disease patients: 15 years of single center experience. J Cardiothorac Surg. 2014;9:84. https://doi.org/10.1186/1749-8090-9-84.CrossRefPubMedPubMedCentral

57.

Cohen MI, Bush DM, Vetter VL, Tanel RE, Wieand TS, Gaynor JW, et al. Permanent epicardial pacing in pediatric patients: seventeen years of experience and 1200 outpatient visits. Circulation. 2001;103:2585–90.CrossRefPubMed

58.

Thomson JDR, Blackburn ME, Van Doorn C, Nicholls A, Watterson KG. Pacing activity, patient and lead survival over 20 years of permanent epicardial pacing in children. Ann Thorac Surg. 2004;77:1366–70. https://doi.org/10.1016/j.athoracsur.2003.08.057.CrossRefPubMed

59.

Walker F, Siu SC, Woods S, Cameron DA, Webb GD, Harris L. Long-term outcomes of cardiac pacing in adults with congenital heart disease. J Am Coll Cardiol. 2004;43:1894–901. https://doi.org/10.1016/j.jacc.2003.12.044.CrossRefPubMed

60.

Roberts AD, Sett S, Leblanc J, Sanatani S. An alternate technique to pacing in complex congenital heart disease: assessment of the left thoracotomy approach. Can J Cardiol. 2006;22:481–4.CrossRefPubMedPubMedCentral

61.

Murayama H, Maeda M, Sakurai H, Usui A, Ueda Y. Predictors affecting durability of epicardial pacemaker leads in pediatric patients. J Thorac Cardiovasc Surg. 2008;135:361–6. https://doi.org/10.1016/j.jtcvs.2007.09.002.CrossRefPubMed

62.

Papadopoulos N, Rouhollapour A, Kleine P, Moritz A, Bakhtiary F. Long-term follow-up after steroid-eluting epicardial pacemaker implantation in young children: a single centre experience. Europace. 2010;12:540–3. https://doi.org/10.1093/europace/euq037.CrossRefPubMed

63.

•• Haight PJ, Stewart RE, Saarel EV, Pettersson GB, Najm HK, Aziz PF. Lateral thoracotomy for epicardial pacemaker placement in patients with congenital heart disease. Interact Cardiovasc Thorac Surg. 2018;26:845–51. https://doi.org/10.1093/icvts/ivx379. This is the largest study of lateral thoracotomy for epicardial lead placement in patients with CHD and inherited arrhythmia syndromes, and it demonstrated acceptable lead performance compared to previous approaches. CrossRefPubMed

64.

•• Punn R, Hanisch D, Motonaga KS, Rosenthal DN, Ceresnak SR, Dubin AM. A pilot study assessing ECG versus ECHO ventriculoventricular optimization in pediatric resynchronization patients. J Cardiovasc Electrophysiol. 2016;27:210–6. https://doi.org/10.1111/jce.12863. This is the only study to compare ECG and echo for VV optimization in pediatric CRT and it demonstrated no difference in outcomes. CrossRefPubMed

65.

Jensen CJ, Liadski A, Bell M, Naber CK, Bruder O, Sabin GV, et al. Echocardiography versus intracardiac electrocardiography-based optimization for cardiac resynchronization therapy: a comparative clinical long-term trial. Herz. 2011;36:592–9. https://doi.org/10.1007/s00059-011-3507-7.CrossRefPubMed

66.

Tamborero D, Vidal B, Tolosana JM, Sitges M, Berruezo A, Silva E, et al. Electrocardiographic versus echocardiographic optimization of the interventricular pacing delay in patients undergoing cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2011;22:1129–34. https://doi.org/10.1111/j.1540-8167.2011.02085.x.CrossRefPubMed

67.

Cheng C-M, Huang J-L, Wu T-J, Su C-S, Pai H-Y, Liao M-F, et al. Comparison of quick optimization of interventricular delay between simple methods: intracardiac electrogram and surface electrocardiogram after cardiac resynchronization therapy. Europace. 2012;14:1317–23. https://doi.org/10.1093/europace/eus061.CrossRefPubMed

Title: Resynchronization Therapy for Patients with Congenital Heart Disease: Are We Ready for Prime Time?
Authors: Scott Anjewierden
Peter F. Aziz
Publication date: 01-09-2018
Publisher: Springer US
Published in: Current Cardiology Reports / Issue 9/2018
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-018-1015-6

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Resynchronization Therapy for Patients with Congenital Heart Disease: Are We Ready for Prime Time?

Abstract

Purpose of Review

Recent Findings

Summary

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 9/2018

Lipid Screening, Action, and Follow-up in Children and Adolescents

Complications of Cardiac Transplantation

Percutaneous Endovascular Aortic Aneurysm Repair for Abdominal Aortic Aneurysm

The Emerging Role of Mobile-Health Applications in the Management of Hypertension

Coronary Artery Calcium Score: the “Mammogram” of the Heart?

An Overview of Clinical Outcomes in Transvenous and Subcutaneous ICD Patients

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page